A recent study has shown that the prevalence of glomerular damage in adults with various forms of sickle cell anemia is much higher than previously thought. Guasch and colleagues investigated the ...
When you have complement 3 (C3) glomerulopathy, a problem with your immune system can damage your kidneys. You’ll take medicine to control your immune system and protect your kidneys.
一起加油。 参考文献: 1. 孙鲁英,王玉,陈淑芳,孙孟里,李晓玫.严格限盐对慢性肾小球肾炎患者血压及尿蛋白的影响【J】.中华内科杂志,2009(12):995-998. 2.Shen WW, Chen HM, Chen H, Xu F, Li LS, Liu ZH. Obesity-related glomerulopathy: body mass index and proteinuria.
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Collapsing glomerulopathy (CG) is a well-recognized distinct morphological pattern of proliferative parenchymal injury leading to rapid graft failure. We conducted a single-center retrospective study ...
Recently, a group of diseases associated with the alternative complement pathway deregulation, which includes paroxysmal nocturnal haemoglobinuria, atypical haemolytic uraemic syndrome and a new ...
A 72-year-old woman presented with nephrotic proteinuria and moderate haematuria. Renal pathology was compatible with immunotactoid glomerulopathy (ITG), for which there is no consensus for ...
On the other hand, as mentioned above, microalbuminuria and even proteinuria are not uncommon in patients with T2DM even in the absence of diabetic glomerulopathy. 5 Although the reason for their ...
Glomerulopathy,Grating Structure, Bernhard Gleich was born in Augsburg, Germany in 1978. He received the B.S, degree in electrical engineering from the Technische Universität München, Munich, Germany, ...
Zaltenibart is under clinical development by Omeros and currently in Phase I for Kidney Disease (Nephropathy).
Meanwhile, ADX-097 provides localized inhibition of the complement system to manage immune-mediated kidney diseases, including lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA ...